Grand Rounds April on Orlando Medical News

Grand Rounds April

Nemours Names CEO for New Children’s Hospital

Roger Oxendale, MBA, has been named CEO of Nemours Children’s Hospital and will be joining the organization in April, 2010. This is a new leadership position for the integrated pediatric facility, under construction at the Lake Nona Medical Campus near Orlando.

Mr. Oxendale is a nationally recognized health care executive with an impressive list of accomplishments. Prior to joining Nemours, he served as CEO of Children’s Hospital of Pittsburgh of UPMC and as president of the Children’s Hospital of Pittsburgh Foundation.

Vascular Vein Centers add ThermaLiteT 1470 Laser System

Vascular Vein Centers is pleased to announce the addition of the new ThermaLite™ 1470 Laser System at all 5 locations. The new laser system offers significant patient benefits including reduced swelling, bruising and no post operative pain that has traditionally been associated with varicose vein surgery.

Varicose veins affect up to 40% of women and 20% of men. Some symptoms include swelling, leg heaviness, fatigue, skin discoloration and pain. Untreated varicose veins can lead to many complications such as ulcers on the surface of the skin. This non-invasive laser procedure is performed at the clinic using local anesthesia and is complete in less than one hour. Following the procedure, patients are encouraged to walk and are able to resume normal activities on the same day.

Orlando Orthopaedic Center’s Annual Cutting Edge Concepts in Orthopaedics & Sports Medicine Seminar

For the sixth consecutive year, the Orlando Orthopaedic Center hosted a continuing education program to benefit the University of Central Florida Student Athletic Trainers’ Organization (UCF SATO). The 2010 6th Annual Cutting Edge Concepts in Orthopaedics & Sports Medicine seminar was hosted on the campus of Lake Brantley High School in February. And once again, attendance at this year’s program shattered the previous record held last year with over 500 in attendance.

The increased attendance also meant an increase in proceeds, and $2,250 was donated to the UCF SATO which will put the funds towards scholarships and assisting with the costs of sending athletic training students to meetings and conferences. Orlando Orthopaedic Center has now donated over $8,000 to UCF SATO over six years of hosting this seminar.

Florida Hospital Establishes Only Heart Transplant Program in Central Florida

Florida Hospital is launching the only heart transplant program in Central Florida. With the addition of two world class physicians to the Florida Hospital team, the first heart transplant in Central Florida is rapidly approaching. Cardiologist Dr. Barbara Czerska and Transplant Surgeon, Dr. Lawrence McBride have joined the Florida Hospital Transplant Center to lead the heart transplant program at Florida Hospital.

It is important for the Central Florida community to have a heart transplant program because it enables patients requiring a heart transplant to have that surgery performed close to home, so they don’t have to commute long distances to be close to heart transplant experts. Being close to the transplant center also allows patients to be nearby during the extended recovery process.

The Florida Hospital Transplant Center performed Central Florida’s first kidney transplant more than 35 years ago and is the area’s only transplant facility replacing multiple organs; the pancreas, the liver, the kidneys and now the heart. The legacy of the Florida Hospital Cardiovascular Institute and the Florida Hospital Transplant Center, make it possible for Florida Hospital to be the location of the first heart transplant performed in Central Florida.

Cardiologist Dr. Barbara Czerska will be supporting Dr. McBride and preparing potential transplant patients to receive a heart when it becomes available.

Florida Hospital Cancer Institute Welcomes Dr. David Decker as New Executive Director

ORLANDO – Dr. David Decker recently joined Florida Hospital Cancer Institute (FHCI) and will serve as the new executive director. He will oversee all operational aspects of FHCI.

Dr. Decker has extensive training and educational background in both Hematology and Oncology. He has published numerous articles in peer-reviewed journals and book chapters and has also presented nationally and internationally at various scientific conferences. He has been an investigator on multiple industry and National Cancer Institute grants. He started and served as the principle investigator of one of the most successful Community Cancer Oncology Programs in the country. Additionally, Dr. Decker has trained and mentored many physicians.

Prior to joining FHCI, Dr. Decker served as Director of Research and Education of the William Beaumont Cancer Treatment Center, and Chief of the Hematology and Oncology division at William Beaumont Hospital in Royal Oak, Mich. He is a graduate of Wayne State University School of Medicine, and completed a residency in Internal Medicine and an Oncology fellowship at the Mayo Clinic in Rochester, Minn. He is a clinical Professor of Medicine at Wayne State University.

Vascular Vein Centers Opens New Office

Vascular Vein Centers is proud to announce the opening of their new medical office located in the Waterford Medical Suites in Orlando on March 1.

Samuel Martin, MD, Vascular Surgeon and Medical Director of Vascular Vein Centers said that they are thrilled to be expanding into a larger space just down the road from the existing office in Waterford Lakes.

Vascular Vein Centers specializes in the treatment of vein disease, which affects 60% of all American women and men. The Centers treat varicose veins, spider veins and other vein disorders. The physicians are all members of the American College of Phlebology.

Vascular Vein Centers has five locations in Orange, Seminole, Lake, Osceola and Polk counties.

Sanford-Burnham Medical Research Institute and Analiza, Inc. Add Large Volume of Compound Solubility Data to PubChem to Assist Future Drug Discovery Efforts

A collaborative project between Sanford-Burnham Medical Research Institute at Lake Nona and Analiza, Inc. has yielded aqueous solubility data for over 20,000 compounds in the NIH Molecular Library within the first 90 days of screening and characterization. The early results of the analysis are proving to be enlightening, with almost 30% of the compounds screened having low solubility – a key factor in disqualifying compounds early in the drug development process, saving later stage time and expense. The reported measurements are now part of PubChem, the largest public database of bioactive molecules.

In total, over 58,000 compounds from the NIH Molecular Libraries Small Molecule Repository will be analyzed during the 12 month agreement. The project is the result of Sanford-Burnham receiving a $600,000 NIH research grant in late 2009. To date, such a large volume of solubility data, as related to chemical structure, has not been available for computational analysis. Knowing the solubility measurements of test compounds will help improve and streamline the early stages of molecular screening. Ultimately, the data will assist future drug discovery efforts by allowing an investigator to select the concentration of each compound to test within their biological studies.

Safe Sitter® Course to be held at South Lake Hospital

Clermont — South Lake Hospital will host a Safe Sitter® course Thursday, April 8 through Friday, April 9, at the National Training Center.

The Safe Sitter® course is a highly structured babysitting preparation course designed for youth ages 11 through 13. The two day course is held from 9:00 a.m. to 4:00 p.m. and covers babysitting basics, child care essentials, and safety for the sitter, injury management, preventing problem behaviors, care of a choking infant and child and the basics of infant and child CPR.

The course includes hands on practice with CPR manikins, small group interactive learning, role-playing and a toddler or preschool guest. Program participants emerge as more confident, responsible and compassionate teens.

The cost for the program is $50. Pre-registration is required and space is limited. Please call 352.394.4071, ext. 4419 for more information and to register.

Health Central recognized as National Hospital of Choice

Ocoee, FL- The American Alliance of Healthcare Providers (AAHCP) recently announced the selection of Health Central in Ocoee as one of the ten winners of the Hospital of Choice Award for the winter quarter. Since 2002, the Hospital of Choice Award has recognized America’s most customer-friendly hospitals based on either an extensive application process or by a secret review of a facility’s public communication and staff interaction with customers.

The application process requires a review of six principal areas of consideration including Standards of Conduct, Performance Management and Improvement, Staff Development and Training, Systems of Communication, Good Citizenship, and Educational and Promotional Material available to consumers. Of the approximately 400 hospitals evaluated and considered for this award, only one hundred hospitals a year are selected. Along with Health Central, other recipients for the winter quarter include Johns Hopkins University Hospital in Baltimore, MD, Howard University Hospital and Georgetown University Hospital in Washington, DC, Virginia Hospital Center in Arlington, VA and The Ohio State University Richard M. Ross Heart Hospital in Columbus, OH. To view the complete list of recipients, visit choicehospitals.com.

Golf Tournament to Benefit those Struggling With Infertility

Orlando, FL — Annika Sorenstam, one of the world’s most celebrated golfers, LPGA and World Golf Hall of Fame Golfer, is the Special Guest and will host a Golf Clinic at the FERTILE DREAMS on the GREENS ProAm Golf Tournament, to be held on Friday, May 7, at the Ritz-Carlton Golf Club Orlando, Grande Lakes, Orlando.

Taking place the weekend of Mother’s Day 2010, the golf event will also showcase a silent auction, luncheon, and attendance by previous Embracing Hope Grant recipients with their families.

Proceeds benefit the Embracing Hope Grant Program which provides financial support of up to $10,000 to those needing assistance to become parents and help cover some of the expenses of medically required fertility treatment. For many, the Embracing Hope Grant for IVF represents their only chance to conceive their biological child. This year we are committed to establishing a grant program for those seeking financial assistance for the Embracing Hope Grant for Adoption as well.

Founded in 2004 by Dr. Mark P. Trolice, Fertility C.A.R.E. Director, and his wife Andrea, Fertile Dreams is a nonprofit organization that offers hope through education and access to resources. Nine million Americans or one in eight are infertile.

Fertile Dreams has awarded over $150,000 in Embracing Hope Grants since 2006. As an all volunteer organization, 100% of all donations and gifts-in-kind benefit the Embracing Hope Grant and the Paths to Parenthood Conferences for fertility awareness and adoption.

For more information, reserve tickets, or make a donation, contact Elizabeth Carellas, Program Director at info@fertiledreams.org Event and sponsorships information is available online at www.FertileDreams.org

Prior event celebrity guests include Brenda Strong, ABC-TVs Desperate Housewives’ Mary Alice and Trista Sutter, the original ABC Bachelorette.

Central Florida Doctor, Michael W. Steppie, MD, To Be On Discovery Health- Mystery Diagnosis With His Rarely Diagnosed CTX Disorder Case

ORLANDO- Michael W. Steppie, MD, President and Medical Director of Associates In Dermatology, will appear on Discovery Channel’s Health- Mystery Diagnosis. Episode 808- The Girl Who Was Covered With Bumps will start airing April 5.

Cerebrotendinous Xanthomatosis (CTX) is a progressive genetic fat (lipid) storage disorder affecting the central nervous system and the skin. People with this disorder are unable to produce the enzyme required to break down certain fats; especially cholesterol. These fats then accumulate and form nodules (Xanthomas) just under the skin. Nodules can also accumulate in the fatty substance that insulates and protects the nerves, disrupting nerve signaling in the brain. It is estimated that there are over 27,000 people in the US who have CTX and have been misdiagnosed or undiagnosed. Because of Dr. Steppie and others the medicine used to treat CTX was approved by the FDA in February 2010.

Dr. Steppie is board certified in Dermatology and Internal Medicine. He specializes in skin cancer and is a MOHS Micrographic Skin Cancer Surgeon. He has been honored with the distinguished American Medical Association Physician Recognition Award numerous times and was voted one of America’s Top Physicians for 2008.

Associates In Dermatology has 9 clinics in Central Florida; Dr. Phillips, East Orlando, Kissimmee, St. Cloud, Davenport, Ocoee, Altamonte Springs and Clermont.

Florida Public Health Institute and Healthmetrics Partners, Inc. Form Innovative Partnership

Lake Worth — The Florida Public Health Institute (FPHI), under the Executive leadership of Dr. Earl Fox, formerly of HRSA in Washington, D.C., has entered into a partnership with Healthmetrics Partners from Massachusetts to provide Public Health managers with the information they need to maximize the effectiveness and efficiency of the medical services they offer.

Per Fox, the FPHI has teamed up with Healthmetrics Partners from Massachusetts to provide their services to Public Health managers because of their excellent track record in improving costs and healthcare outcomes. He further added that the role of FPHI will be to develop education and training programs to support these projects, identify local experts and use the data to identify ways to improve state regulations and policies that govern the delivery of medical services.

Mr. Michael Napier, the Administrator of Seminole County Health Department and President elect of the Florida Association of County Health Officers said that as steward of the Public Health System that utilizes taxpayer’s dollars they have an obligation to adopt best practices to achieve outcome optimization in the care they provide. Like every business public or private they are always looking for ways to lower costs and simultaneously improve the quality of service.

ImaCor Introduces New Device

ImaCor, Inc. has recently introduced a new device that will assist in the management of hemodynamically unstable patients in the ICU and perioperative situations. The ClariTEE™ probe is a miniaturized, disposable transesophageal echocardiography (TEE) probe that can be used in the assessment and management of cardiac function, intravascular volume status, and the presence of tamponade.

Unlike conventional TEE probes which are large in diameter and require anesthesia or sedation, the ClariTEE probe is the size of a naso-gastric tube and can be placed in a non-sedated patient. Due to its small size the ClariTEE™ probe that can be left in a patient for up to 72 hours. Whereas conventional TEE probes provide detailed cardiac information at that point in time, the smaller sized ClariTEE probe is designed to remain indwelling for an extended period of time allowing critical care physicians to monitor a patient’s response to medical interventions such as volume resuscitation and administration of vasoactive agents.

ImaCor has successfully completed a clinical trial and is FDA cleared in the United States and has recently successfully completed evaluations at several major medical centers in the United States, and has only recently started commercializing the system.

MedFast Urgent Care Center coming to Parrish Healthcare Center at Port St. John

PORT ST. JOHN, FL —MedFast Urgent Care Centers will open a new location inside Port St. John’s largest outpatient healthcare center—Parrish Healthcare Center, located on Port St. John Parkway. The new $1.1 million urgent care center addition will be completed by summer 2010.

Parrish Medical Center made the largest healthcare investment in the history of the Port St. John-North Cocoa-Canaveral Groves communities when they constructed the state’s first silver LEED-certified green and medically advanced outpatient healthcare center in 2007 according to J.J. Parrish III, chairman of the Parrish Medical Center board of directors, and the addition of the MedFast Urgent Care Center marks another milestone in the growth of Port St. John and surrounding communities.

The MedFast Urgent Care Center at Parrish Healthcare Center at Port St. John will provide the community with its first comprehensive, multidisciplinary emergent care facility, featuring emergency room-experienced physicians, physician assistants and nurse practitioners, along with a full complement of advanced treatment and diagnostic imaging services (from labs and x-rays to MRI, CT and more) in one convenient location.

Because it will be staffed by MedFast emergency room-experienced physicians, the center will offer much more than traditional urgent care services. The new center will treat all types of emergent or urgent illnesses or injuries such as fractures, cuts that need stitches, sprains, asthma/bronchitis/sinusitis, as well as treat abdominal pain, respiratory infections, pelvic pain, headache, infections, influenza, and sports and other injuries. In addition, the center will offer occupational medicine/workers comp and corporate health services, physicals, and vaccinations.

Maureen Rupe, a Port St. John resident and Parrish Medical Center board member, also serves on the advisory committee of Port St. John and Canaveral Groves residents. She said that community involvement has been an important factor in the decision to open an urgent care center to serve Port St. John, Canaveral Groves and north Cocoa.

The Urgent Care Center will bring the total Parrish investment in Port St. John to more than $35 million.

Among services available now at the Parrish Healthcare Center at Port St. John are advanced digital diagnostic technology (digital mammography, CT, MRI, Ultrasound); full-time primary care physician specialists; laboratory services; a sleep disorder center; physical therapy; diabetes education; wound care; occupational therapy; stress testing and other heart-related services.

Tags:

None

Bookmark: